CoreCap Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.5K Buy
+3,273
New +$39.8K ﹤0.01% 1549
2022
Q4
$2.43M Sell
114,771
-1,989
-2% -$41.2K 0.17% 100
2022
Q3
$2.37M Buy
+116,760
New +$2.33M 0.2% 93

Other funds holding BTAL

CoreCap Advisors's BTAL Position: Q2 2026 in Review

CoreCap Advisors opened a new position in AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026: 3,273 shares worth $36.5K. The stake represents ﹤0.01% of the portfolio and ranks #1549 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in BTAL as recently as Q4 2022.

CoreCap Advisors first reported a position in BTAL in Q3 2022 and has held it in 3 quarters since. The position peaked at $2.43M in Q4 2022. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • CoreCap Advisors held 3,273 shares of AGF US Market Neutral Anti-Beta Fund worth $36.5K as of Q2 2026.
  • AGF US Market Neutral Anti-Beta Fund was a new CoreCap Advisors position in Q2 2026.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1549 holding.
  • CoreCap Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2022 and has held it in 3 quarters since.
  • CoreCap Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $2.43M in Q4 2022.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.